Literature DB >> 32279723

Buprenorphine in the Treatment of Chronic Pain.

Gregory D Rudolf1.   

Abstract

The burden of chronic pain in the United States is staggering. Concurrently, the problems associated with use of opioids for treatment of chronic pain have been prominently scrutinized in recent years. Buprenorphine is an opioid that is available for treatment of both chronic pain and opioid use disorder. Its use for chronic pain has been hampered by various factors including complex and often misunderstood pharmacology, challenges to transition and induction to buprenorphine from other opioids, provider perceptions around the legality of prescribing sublingual buprenorphine for pain, and insurance coverage limitations. This article reviews the pharmacology and clinical effectiveness of buprenorphine in the context of chronic pain treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buprenorphine; Chronic pain; Opioids

Mesh:

Substances:

Year:  2020        PMID: 32279723     DOI: 10.1016/j.pmr.2020.02.001

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  4 in total

1.  Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam.

Authors:  Dana Button; Ryan Cook; Caroline King; Tong Thi Khuyen; Lynn Kunkel; Gavin Bart; Dinh Thanh Thuy; Diep Bich Nguyen; Christopher K Blazes; Le Minh Giang; P Todd Korthuis
Journal:  Int J Drug Policy       Date:  2021-11-09

2.  Pain management in patients with chronic kidney disease and end-stage kidney disease.

Authors:  Payel J Roy; Melanie Weltman; Laura M Dember; Jane Liebschutz; Manisha Jhamb
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-11       Impact factor: 3.416

Review 3.  Conolidine: A Novel Plant Extract for Chronic Pain.

Authors:  Amber N Edinoff; Akash S Patel; Mitchell W Baker; Jesse Lawson; Christopher Wolcott; Elyse M Cornett; Kambiz Sadegi; Adam M Kaye; Alan D Kaye
Journal:  Anesth Pain Med       Date:  2021-12-08

4.  Antinociceptive effects of the combined use of butorphanol and buprenorphine in mice.

Authors:  Kazumasu Sasaki; Tatsuya Ishikawa; Kazutaka Ikeda; Shinya Kasai
Journal:  Neuropsychopharmacol Rep       Date:  2021-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.